Astellas to transfer Protopic rights in Japan
This article was originally published in Scrip
Executive Summary
Astellas is to transfer all detailing and promotional activities for Protopic, the topical formulation of tacrolimus, to the mid-sized Japanese company Maruho, effective 1 April next year.